Live Breaking News & Updates on Matthias Liechti

Stay updated with breaking news from Matthias liechti. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

MDMA as psychiatric treatment moves closer to US approval

Long-awaited clinical trial data show psychedelic drug is effective at treating post-traumatic stress disorder in a diversity of people. Long-awaited clinical trial data show psychedelic drug is effective at treating post-traumatic stress disorder in a diversity of people. ....

United States , San Francisco , Jennifer Mitchell , Oderick Turner , Vaile Wright , Matthias Liechti , Oregon Health Science University In Portland , Multidisciplinary Association For Psychedelic Studies , American Psychological Association , Drug Administration , University Of California , University Of Basel , Multidisciplinary Association , Psychedelic Studies , San Jose , Oregon Health , Science University ,

PTSD may be cured by 'ecstasy' therapy: breakthrough MDMA study

MDMA plus psychotherapy can treat PTSD so well that people no longer have symptoms of the disorder, according to new research. ....

New York , United States , Jennifer Mitchell , Matthias Liechti , Berra Yazar Klosinski , New York Times , University Of Basel , Drug Enforcement Agency , Drug Administration , American Psychiatric Association , University Of California San Francisco , Nature Medicine , California San , Medical Breakthroughs , Mental Illness ,

Combining MDMA With Psilocybin Or LSD Could Reduce Difficult Trips, New Study Shows - Mind Medicine (NASDAQ:MNMD)

Recent peer-reviewed research published in the journal Nature posits that a small dose of MDMA could be helpful against uncomfortable or difficult experiences and amplify positive ones when combined with either psilocybin or LSD. ....

City Of , United Kingdom , Matthias Liechti , York University Langone Center , Imperial College London , University Hospital Basel , New York University , Langone Center , Psychedelic Medicine , University Hospital ,

Leading Proxy Advisory Firm ISS Recommends MindMed Shareholders Vote FOR All Six Company Nominees

ISS Believes Company’s Director Nominees Represent an “Unusually Strong” Group of Current and Former Executives From Relevant Fields and Are Best Suited to Continue Overseeing. | June 5, 2023 ....

New York , United States , Matthias Liechti , Robert Barrow , Medicine Mindmed Inc , Morrow Sodali , Company Annual Report On Form , Company Or Mindmed , University Hospital Basel , Institutional Shareholder Services Inc , Company Quarterly Report On Form , Company Board , Greenleaf Health , Exchange Commission , Mind Medicine , Institutional Shareholder Services , Annual Meeting , Chief Executive Officer , Mindmed Board , Brokers Call , Call Toll Free , Annual Report , Quarterly Report , Note Regarding Forward Looking Statements , Financial Condition , Electronic Disclosure ,

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Q1 2023 Earnings Call Transcript

Operator: Good afternoon, and welcome to the Mind Medicine First Quarter 2023 Financial Results and Corporate Update Conference call. Currently, all participants are in listen-only mode. ....

United States , University Hospital , Miami Beach , Matthias Liechti , Dave Gryska , Brian Abrahams , Dan Karlin , Elemer Piros , Felix Mueller , Francois Brisebois , Markr Sullivan , Charles Duncan , Schond Greenway , Rob Barrow , Miri Halperin Wernli , University Hospital Of Psychiatry , University Hospital Basel , Exchange Commission , American Society Of Clinical Psychopharmacology Annual Meeting , Cantor Fitzgerald , Jazz Pharmaceuticals , Maastricht University , Medicine Mindmed Inc , Gw Pharmaceuticals , Mind Medicine , Call Transcript May ,